Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Heise

Showing results (31-40 of 150) with videos related to

Pageof 15
Sort By:
Diabetes Care|June 26, 2007
Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetesKlaus Rave, Tim Heise, Andreas Pfützner, et al.
Journal of Diabetes Science and Technology|April 9, 2015
How to Assess the Quality of Glucose Clamps? Evaluation of Clamps Performed With ClampArt, a Novel Automated Clamp DeviceCarsten Benesch, Tim Heise, Oliver Klein, et al.
Diabetes, Obesity & Metabolism|October 7, 2016
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trialTim Heise, Eric Zijlstra, Leszek Nosek, et al.
Journal of Hypertension|June 24, 2006
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patientsThomas Kaiser, Tim Heise, Leszek Nosek, et al.
Diabetes, Obesity & Metabolism|December 8, 2022
Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesitySusanna Bianzano, Matias Nordaby, Leona Plum-Mörschel, et al.
The British Journal of Nutrition|June 15, 2007
Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucoseKlaus Rave, Kerstin Roggen, Sibylle Dellweg, et al.
Clinical Pharmacokinetics|February 17, 2017
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 DiabetesTim Heise, Thomas R Pieber, Thomas Danne, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 7, 2022
Selective Inhibition of 11beta-Hydroxysteroiddehydrogenase-1 with BI 187004 in Patients with Type 2 Diabetes and Overweight or Obesity: Safety, Pharmacokinetics, and Pharmacodynamics After Multiple Dosing Over 14 DaysSusanna Bianzano, Cornelia Schepers, Michael Wolff, et al.
Frontiers in Neuroscience|January 30, 2023
Limited evidence for sympathetic neural overactivation in older patients with type 2 diabetes mellitusKarsten Heusser, Jens Tank, André Diedrich, et al.
Journal of Clinical Pharmacology|July 31, 2010
Effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutideChristoph Kapitza, Milan Zdravkovic, Eric Zijlstra, et al.
Pageof 15

Showing results (31-40 of 150) with videos related to

Sort By:
Pageof 15
Diabetes Care|June 26, 2007
Coverage of postprandial blood glucose excursions with inhaled technosphere insulin in comparison to subcutaneously injected regular human insulin in subjects with type 2 diabetesKlaus Rave, Tim Heise, Andreas Pfützner, et al.
Journal of Diabetes Science and Technology|April 9, 2015
How to Assess the Quality of Glucose Clamps? Evaluation of Clamps Performed With ClampArt, a Novel Automated Clamp DeviceCarsten Benesch, Tim Heise, Oliver Klein, et al.
Diabetes, Obesity & Metabolism|October 7, 2016
Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trialTim Heise, Eric Zijlstra, Leszek Nosek, et al.
Journal of Hypertension|June 24, 2006
Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patientsThomas Kaiser, Tim Heise, Leszek Nosek, et al.
Diabetes, Obesity & Metabolism|December 8, 2022
Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesitySusanna Bianzano, Matias Nordaby, Leona Plum-Mörschel, et al.
The British Journal of Nutrition|June 15, 2007
Improvement of insulin resistance after diet with a whole-grain based dietary product: results of a randomized, controlled cross-over study in obese subjects with elevated fasting blood glucoseKlaus Rave, Kerstin Roggen, Sibylle Dellweg, et al.
Clinical Pharmacokinetics|February 17, 2017
A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 DiabetesTim Heise, Thomas R Pieber, Thomas Danne, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|November 7, 2022
Selective Inhibition of 11beta-Hydroxysteroiddehydrogenase-1 with BI 187004 in Patients with Type 2 Diabetes and Overweight or Obesity: Safety, Pharmacokinetics, and Pharmacodynamics After Multiple Dosing Over 14 DaysSusanna Bianzano, Cornelia Schepers, Michael Wolff, et al.
Frontiers in Neuroscience|January 30, 2023
Limited evidence for sympathetic neural overactivation in older patients with type 2 diabetes mellitusKarsten Heusser, Jens Tank, André Diedrich, et al.
Journal of Clinical Pharmacology|July 31, 2010
Effect of three different injection sites on the pharmacokinetics of the once-daily human GLP-1 analogue liraglutideChristoph Kapitza, Milan Zdravkovic, Eric Zijlstra, et al.
Pageof 15